Admedus Ltd appointed its CFO, Catherine Costello, to the company's board as interim executive director.
Costello's appointment follows Mathew Ratty's resignation from the board and fulfills a rule requiring the company to have two resident Australian directors, Admedus said in a news release.
The company's board is looking for a permanent director to replace Ratty.
Australia-based Admedus develops healthcare technologies and devices for treating heart diseases, among others.
